PL1675611T3 - Lecznicze zastosowania peptydu C - Google Patents

Lecznicze zastosowania peptydu C

Info

Publication number: PL1675611T3
Authority: PL; Poland
Prior art keywords: peptide; therapeutic applications; diabetes; administration; treatment
Prior art date: 2003-10-13

Application number

PL04768872T

Other languages

English (en)

Inventor

Karin Ekberg

John Wahren

Original Assignee

Creative Peptides Sweden Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-13

Filing date

2004-10-13

Publication date

2009-05-29

2004-10-13 Application filed by Creative Peptides Sweden Ab filed Critical Creative Peptides Sweden Ab

2009-05-29 Publication of PL1675611T3 publication Critical patent/PL1675611T3/pl

Links

230000001225 therapeutic effect Effects 0.000 title 1
208000002249 Diabetes Complications Diseases 0.000 abstract 2
VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 abstract 1
108010075254 C-Peptide Proteins 0.000 abstract 1
206010012655 Diabetic complications Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL04768872T 2003-10-13 2004-10-13 Lecznicze zastosowania peptydu C PL1675611T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0323979.5A GB0323979D0 (en)	2003-10-13	2003-10-13	Therapeutic applications for c-peptide
EP04768872A EP1675611B1 (en)	2003-10-13	2004-10-13	Therapeutic applications for c-peptide
PCT/GB2004/004341 WO2005039627A2 (en)	2003-10-13	2004-10-13	Therapeutic applications for c-peptide

Publications (1)

Publication Number	Publication Date
PL1675611T3 true PL1675611T3 (pl)	2009-05-29

Family

ID=29559214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04768872T PL1675611T3 (pl)	2003-10-13	2004-10-13	Lecznicze zastosowania peptydu C

Country Status (12)

Country	Link
US (1)	US7964558B2 (pl)
EP (1)	EP1675611B1 (pl)
AT (1)	ATE416785T1 (pl)
AU (1)	AU2004283526A1 (pl)
CA (1)	CA2542172A1 (pl)
DE (1)	DE602004018352D1 (pl)
DK (1)	DK1675611T3 (pl)
ES (1)	ES2319427T3 (pl)
GB (1)	GB0323979D0 (pl)
NZ (1)	NZ546912A (pl)
PL (1)	PL1675611T3 (pl)
WO (1)	WO2005039627A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009046851A1 (en) *	2007-09-11	2009-04-16	Mondobiotech Laboratories Ag	Cgrp as a therapeutic agent
GB0723250D0 (en) *	2007-11-28	2008-01-09	Univ Leeds	Compositions and methods for reducing macrovascular complications in diabetic patients
US8410049B2 (en) *	2009-10-28	2013-04-02	Cebix	Methods and kits for preventing hypoglycemia
WO2011081915A2 (en) *	2009-12-15	2011-07-07	Cebix Inc.	Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
JP2013533217A (ja)	2010-05-17	2013-08-22	セビックス・インコーポレイテッド	Ｐｅｇ化ｃ−ペプチド
EP2881120B1 (en)	2012-08-06	2019-08-07	Kangwon National University University-Industry Cooperation Foundation	Composition containing c-peptide for preventing or treating diabetic retinopathy
RU2522897C1 (ru) *	2013-04-16	2014-07-20	Закрытое акционерное общество "ФАРМ-ХОЛДИНГ"	Твердая кишечнорастворимая лекарственная форма с-пептида проинсулина для перорального применения (варианты) и способ ее получения (варианты)
ES2927977T3 (es)	2017-02-06	2022-11-14	Biotempt Bv	Moduladores peptídicos de la interacción entre el péptido C humano y el receptor de elastina humana para uso terapéutico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL66611A0 (en)	1981-08-27	1982-12-31	Lilly Co Eli	Pharmaceutical formulations comprising human insulin and human c-peptide
DE3326473A1 (de)	1983-07-22	1985-01-31	Hoechst Ag, 6230 Frankfurt	Pharmazeutisches mittel zur behandlung des diabetes mellitus
SE520392C2 (sv)	1996-09-27	2003-07-01	Creative Peptides Sweden Ab C	Specifika peptider för behandling av diabetes mellitus
DE10041478A1 (de)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
GB0022342D0 (en) *	2000-09-12	2000-10-25	Creative Peptides Sweden Ab	Reduction of the electrocardiographic QT interval
DE10055857A1 (de)	2000-11-10	2002-08-22	Creative Peptides Sweden Ab Dj	Neue pharmazeutische Depotformulierung
US20020077317A1 (en)	2000-12-15	2002-06-20	Das Undurti Narasimha	Method of potentating the action of 2-methoxyoestradiol, statins and C-peptide of proinsulin

2003
- 2003-10-13 GB GBGB0323979.5A patent/GB0323979D0/en not_active Ceased
2004
- 2004-10-13 NZ NZ546912A patent/NZ546912A/en unknown
- 2004-10-13 US US10/575,701 patent/US7964558B2/en not_active Expired - Fee Related
- 2004-10-13 ES ES04768872T patent/ES2319427T3/es not_active Expired - Lifetime
- 2004-10-13 EP EP04768872A patent/EP1675611B1/en not_active Expired - Lifetime
- 2004-10-13 CA CA002542172A patent/CA2542172A1/en not_active Abandoned
- 2004-10-13 DK DK04768872T patent/DK1675611T3/da active
- 2004-10-13 WO PCT/GB2004/004341 patent/WO2005039627A2/en not_active Ceased
- 2004-10-13 AT AT04768872T patent/ATE416785T1/de not_active IP Right Cessation
- 2004-10-13 PL PL04768872T patent/PL1675611T3/pl unknown
- 2004-10-13 DE DE602004018352T patent/DE602004018352D1/de not_active Expired - Lifetime
- 2004-10-13 AU AU2004283526A patent/AU2004283526A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2542172A1 (en)	2005-05-06
DK1675611T3 (da)	2009-04-06
EP1675611A2 (en)	2006-07-05
US20070082842A1 (en)	2007-04-12
ES2319427T3 (es)	2009-05-07
ATE416785T1 (de)	2008-12-15
WO2005039627A3 (en)	2005-07-28
US7964558B2 (en)	2011-06-21
NZ546912A (en)	2009-07-31
WO2005039627A2 (en)	2005-05-06
DE602004018352D1 (de)	2009-01-22
GB0323979D0 (en)	2003-11-19
EP1675611B1 (en)	2008-12-10
AU2004283526A1 (en)	2005-05-06

Similar Documents

Publication	Publication Date	Title
MY145590A (en)	2012-02-29	Phenylacetamides and their use as glucokinase modulators
MXPA05007470A (es)	2005-09-21	Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
CA2683786C (en)	2021-10-26	Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
BR9906813A (pt)	2001-03-20	Método para administração de insulina aspb28- humana
IL154888A (en)	2013-12-31	Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
WO2004050115A3 (en)	2004-07-22	Combination treatment using exendin-4 and thiazolidinediones
NZ603399A (en)	2014-09-26	Pegylated c-peptide
DE602006020070D1 (de)	2011-03-24	Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie
GB2431346B (en)	2010-01-27	A combination composition comprising paracetamol and ibuprofen
GB0323979D0 (en)	2003-11-19	Therapeutic applications for c-peptide
AU7862401A (en)	2002-03-04	Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
WO2007018588A8 (en)	2008-05-08	Stable pharmaceutical composition comprising linezolid form iv
NZ528164A (en)	2006-03-31	Use of flumazenil to produce a medicament for the treatment of cocaine dependency
PL368686A1 (pl)	2005-04-04	Nowe aminobenzofenony
GB0606001D0 (en)	2006-05-03	Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
TW200724146A (en)	2007-07-01	Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
IL173822A0 (en)	2006-07-05	Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
WO2007135123A3 (en)	2008-03-13	Mirtazapine for the treatment of neuropathic pain
GB0205898D0 (en)	2002-04-24	Treatment of type I diabetes mellitus
EA200400478A1 (ru)	2005-12-29	Способ лечения висцеровертеброгенного болевого синдрома
GB0208129D0 (en)	2002-05-22	Method of treatment
DE60120371D1 (de)	2006-07-20	Verwendung von wachstumshormon in niederen dosen
MD3503G2 (ro)	2008-09-30	Metodă de cupare a sindromului algic
UA85523C2 (ru)	2009-01-26	Применение n-стеароилэтаноламина в качестве лекарственного средства для терапии сахарного диабета і и іі типов
RU2002127274A (ru)	2004-12-27	Применение препарата ветом-7048 впервые в качестве лекарственного препарата при лечении атрофии мозга, гидроцефалии мозга